ChiCTR2200056193
结束
/
/
/
2022-02-01
/
/
N/A
Hiwa omer: please submit the approval letter of IRB
Sonographic Measurement of Splenic Size and its Correlation with Body Parameters in Kurdish Population
This study aims to establish reference value of splenic dimensions, volume and its correlation to the different body parameters in Kurdish population
连续入组
其它
N/A
N/A
All funding was covered by authors.
/
300
/
2020-08-07
2021-03-05
/
Normal healthy Kurdish adult male and female population in Sulaimani region who had normal complete blood count (CBC)；
请登录查看Subjects in this study will fill a short-standardized interview questionnaire to exclude any previous or current conditions that might involve the size of the spleen & exclusion criteria were include: 1. Subjects with age younger than 20 years. 2. Clinical or laboratory evidence of infection or jaundice either at the time of the examination or within at least 6 weeks prior to the examination) 3. History of Rheumatoid disease 4. Anemia or haemoglobinopathies (thalassemia and sickle cell anemia). 5. Subjects with Hx of lymphoproliferative disorders or Myeloproliferative neoplasm 6. Subjects in whom the entire length of the spleen could not be properly documented by US or sonographically detectable focal spleen lesions. 7. History of splenic trauma& or those with partial splenectomy. 8. Liver diseases (cirrhosis or portal hypertension). 9. Gravid women. 10. Non-Kurdish races.；
请登录查看medical school, Faculty of Medical Science, University of Sulaimani
/
medical school, Faculty of Medical Science, University of Sulaimani的其他临床试验
伊拉克苏莱曼尼大学的其他临床试验
- COVID-19 associated with pulmonary mucormycosis; a series of four cases
- Hiwa omer: please submit the approval letter of IRB
- Post COVID-19 pulmonary complications: a single center experience
- Large vessel thrombosis in patients with COVID-19
- Severe Reluctant COVID-19 Patients Responding to Convalescent Plasma; A case series
- Combined operation for coronary artery bypass grafting and mitral valve replacement; risk and outcome
- Bilateral Thoracic trauma
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
同适应症药物临床试验
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04